Twareat Medical Care Co. (9627.SR) — Financial statements
Income statement, balance sheet, and cash flow for Twareat Medical Care Co. — annual and quarterly history with growth and margin analysis.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue & Gross Profit | |||||
| Revenue | 183↓4.5% | 192↑24.0% | 155↑3.5% | 150 | |
| Cost of Revenue | 139↑4.7% | 133↑25.0% | 106↑17.9% | 90 | |
| Gross Profit | 44↓25.4% | 59↑21.8% | 48↓18.5% | 59 | |
| Operating Expenses | |||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 0.00↓100.0% | 33↓2.6% | 34↑5.8% | 32 | |
| Other Expenses | 51 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 51↑53.1% | 33↓2.6% | 34↑5.8% | 32 | |
| Total Costs & Expenses | 190↑14.4% | 166↑18.3% | 141↑14.7% | 123 | |
| Operating Results | |||||
| Operating Income | -7↓127.7% | 26↑80.9% | 14↓47.6% | 27 | |
| Depreciation & Amortization | 0.00↓100.0% | 4↑28.1% | 3↑100.8% | 2 | |
| EBITDA | -7↓123.8% | 30↑54.7% | 19↓34.2% | 29 | |
| EBIT | -7↓127.6% | 26↑59.9% | 16↓41.8% | 28 | |
| Interest & Other Income | |||||
| Net Interest Income | 0.00↑100.0% | -0.78↓41.6% | -0.55↑16.8% | -0.66 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00↓100.0% | 0.78↑41.6% | 0.55↓16.8% | 0.66 | |
| Non-Operating Income | 0.00↑100.0% | -0.14↑92.6% | -2↓186.4% | -0.68 | |
| Other Income / Expenses | 7↑1211.6% | -0.64↓145.6% | 1↑7974.7% | 0.02 | |
| Income Before Tax | 0.00↓100.0% | 25↑60.5% | 16↓42.4% | 27 | |
| Income Tax Expense | 0.00↓100.0% | 1↑3.0% | 1↓11.5% | 2 | |
| Net Income & EPS | |||||
| Net Income from Continuing Operations | 0.00↓100.0% | 24↑66.0% | 14↓44.3% | 25 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -10↓143.9% | 24↑66.0% | 14↓44.3% | 25 | |
| Bottom-Line Net Income | -10↓143.9% | 24↑66.0% | 14↓44.3% | 25 | |
| EPS (Basic) | -0.26↓144.1% | 0.59↑68.6% | 0.35↓45.3% | 0.64 | |
| EPS (Diluted) | -0.26↓144.1% | 0.59↑68.6% | 0.35↓45.3% | 0.64 | |
| Weighted Average Shares | 40↑0.0% | 40↑0.0% | 40↑0.0% | 40 | |
| Weighted Average Diluted Shares | 40↑0.0% | 40↑0.0% | 40↑0.0% | 40 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.